Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 13

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part II, Item 4
Chunk 13
---
 existing at that time. The reinsurance agreement is subject to an overall limit, with approximately $3.0 billion remaining as of September 30, 2025. As a result of the reinsurance transaction, amounts payable are offset by a corresponding reinsurance recoverable, provided the increased recoverable remains within the overall Berkshire limit. As of both September 30, 2025 and 2024, market risk benefits (shown in the table net of nonperformance risk as of September 30, 2025) were predominantly reinsured by Berkshire, which is rated AA+ by an NRSRO. As of September 30, 2025, approximately 100% of the Berkshire recoverable is secured by assets in a trust. 

Note 11 – Investments

The following table summarizes the Company's investments by category and current or long-term classification:September 30, 2025December 31, 2024(In millions)CurrentLong-TermTotalCurrentLong-TermTotalDebt securities$490 $7,861 $8,351 $463 $8,960 $9,423 Equity securities17 3,500 3,517 7 554 561 Commercial mortgage loans100 1,158 1,258 108 1,243 1,351 Policy loans— 1,080 1,080 — 1,156 1,156 Other long-term investments— 4,884 4,884 — 4,576 4,576 Short-term investments276 — 276 170 — 170 Total$748 $16,489 $17,237 Investments classified as assets of businesses held for sale (1)(83)(1,361)(1,444)Investments per Consolidated Balance Sheets$883 $18,483 $19,366 $665 $15,128 $15,793 (1) Investments related to the HCSC transaction that were held for sale as of December 31, 2024. These investments were primarily comprised of debt securities.

19

A.Investment Portfolio

Debt Securities

The amortized cost and fair value by contractual maturity periods for debt securities were as follows as of September 30, 2025:(In millions)AmortizedCostFairValueDue in one year or less$653 $573 Due after one year through five years3,649 3,639 Due